nodes	percent_of_prediction	percent_of_DWPC	metapath
Gamma Hydroxybutyric Acid—SLC16A3—Pyruvate metabolism—CRABP1—liver cancer	0.02	0.0612	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.0125	0.0383	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—liver cancer	0.0121	0.037	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.012	0.0365	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Pyruvate metabolism—CRABP1—liver cancer	0.0108	0.033	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00992	0.0303	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00946	0.0289	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—liver cancer	0.00655	0.02	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Ion channel transport—SLC9C1—liver cancer	0.00599	0.0183	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.0057	0.0174	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00566	0.0173	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00566	0.0173	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.00544	0.0166	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00536	0.0164	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00511	0.0156	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—liver cancer	0.0047	0.0144	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00451	0.0138	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00447	0.0137	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00447	0.0137	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.0043	0.0131	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Orphan transporters—ANXA2—liver cancer	0.004	0.0122	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—HBE1—liver cancer	0.00392	0.012	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Orphan transporters—NR1H4—liver cancer	0.00378	0.0115	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Viral infection—Doxorubicin—liver cancer	0.00321	0.00477	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Sorafenib—liver cancer	0.0032	0.00475	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood uric acid increased—Epirubicin—liver cancer	0.00319	0.00474	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperbilirubinaemia—Doxorubicin—liver cancer	0.00318	0.00473	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypocalcaemia—Doxorubicin—liver cancer	0.00316	0.0047	CcSEcCtD
Gamma Hydroxybutyric Acid—Thinking abnormal—Doxorubicin—liver cancer	0.00316	0.0047	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Sorafenib—liver cancer	0.00315	0.00469	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Sorafenib—liver cancer	0.00315	0.00469	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—CYCS—liver cancer	0.00313	0.00957	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00313	0.00465	CcSEcCtD
Gamma Hydroxybutyric Acid—Phosphatase alkaline increased—Epirubicin—liver cancer	0.00313	0.00465	CcSEcCtD
Gamma Hydroxybutyric Acid—Hiccups—Epirubicin—liver cancer	0.00313	0.00465	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperuricaemia—Doxorubicin—liver cancer	0.00312	0.00464	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis contact—Epirubicin—liver cancer	0.00309	0.0046	CcSEcCtD
Gamma Hydroxybutyric Acid—Abnormal dreams—Epirubicin—liver cancer	0.00309	0.0046	CcSEcCtD
Gamma Hydroxybutyric Acid—Dry mouth—Sorafenib—liver cancer	0.00308	0.00458	CcSEcCtD
Gamma Hydroxybutyric Acid—Cystitis noninfective—Epirubicin—liver cancer	0.00306	0.00455	CcSEcCtD
Gamma Hydroxybutyric Acid—Creatinine increased—Doxorubicin—liver cancer	0.00304	0.00452	CcSEcCtD
Gamma Hydroxybutyric Acid—Cystitis—Epirubicin—liver cancer	0.00302	0.00449	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Sorafenib—liver cancer	0.003	0.00446	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Sorafenib—liver cancer	0.00297	0.00442	CcSEcCtD
Gamma Hydroxybutyric Acid—Fluid retention—Epirubicin—liver cancer	0.00297	0.00442	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Sorafenib—liver cancer	0.00296	0.00441	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood uric acid increased—Doxorubicin—liver cancer	0.00295	0.00438	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Sorafenib—liver cancer	0.00293	0.00436	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.0029	0.00884	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.0029	0.00431	CcSEcCtD
Gamma Hydroxybutyric Acid—Hiccups—Doxorubicin—liver cancer	0.0029	0.00431	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Sorafenib—liver cancer	0.00288	0.00428	CcSEcCtD
Gamma Hydroxybutyric Acid—Cramps of lower extremities—Epirubicin—liver cancer	0.00287	0.00427	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis contact—Doxorubicin—liver cancer	0.00286	0.00425	CcSEcCtD
Gamma Hydroxybutyric Acid—Abnormal dreams—Doxorubicin—liver cancer	0.00286	0.00425	CcSEcCtD
Gamma Hydroxybutyric Acid—Coma—Epirubicin—liver cancer	0.00286	0.00425	CcSEcCtD
Gamma Hydroxybutyric Acid—Ecchymosis—Epirubicin—liver cancer	0.00283	0.00421	CcSEcCtD
Gamma Hydroxybutyric Acid—Mouth ulceration—Epirubicin—liver cancer	0.00283	0.00421	CcSEcCtD
Gamma Hydroxybutyric Acid—Bladder pain—Epirubicin—liver cancer	0.00283	0.00421	CcSEcCtD
Gamma Hydroxybutyric Acid—Cystitis noninfective—Doxorubicin—liver cancer	0.00283	0.00421	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Ion channel transport—ATP7B—liver cancer	0.0028	0.00856	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Cystitis—Doxorubicin—liver cancer	0.0028	0.00416	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00276	0.00844	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00275	0.00409	CcSEcCtD
Gamma Hydroxybutyric Acid—Fluid retention—Doxorubicin—liver cancer	0.00275	0.00409	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertonia—Epirubicin—liver cancer	0.00274	0.00408	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disability—Epirubicin—liver cancer	0.00272	0.00404	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—F2—liver cancer	0.0027	0.00825	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspnoea—Sorafenib—liver cancer	0.00269	0.004	CcSEcCtD
Gamma Hydroxybutyric Acid—Lymphadenopathy—Epirubicin—liver cancer	0.00266	0.00396	CcSEcCtD
Gamma Hydroxybutyric Acid—Cramps of lower extremities—Doxorubicin—liver cancer	0.00266	0.00396	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Sorafenib—liver cancer	0.00266	0.00395	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00265	0.00809	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00265	0.00809	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Coma—Doxorubicin—liver cancer	0.00265	0.00393	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Sorafenib—liver cancer	0.00263	0.0039	CcSEcCtD
Gamma Hydroxybutyric Acid—Bladder pain—Doxorubicin—liver cancer	0.00262	0.00389	CcSEcCtD
Gamma Hydroxybutyric Acid—Mouth ulceration—Doxorubicin—liver cancer	0.00262	0.00389	CcSEcCtD
Gamma Hydroxybutyric Acid—Ecchymosis—Doxorubicin—liver cancer	0.00262	0.00389	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00261	0.00388	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Sorafenib—liver cancer	0.00261	0.00388	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Sorafenib—liver cancer	0.0026	0.00387	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Sorafenib—liver cancer	0.00258	0.00384	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Sorafenib—liver cancer	0.00258	0.00384	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—liver cancer	0.00254	0.00775	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypertonia—Doxorubicin—liver cancer	0.00254	0.00377	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disability—Doxorubicin—liver cancer	0.00251	0.00374	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00251	0.00765	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Sorafenib—liver cancer	0.00247	0.00367	CcSEcCtD
Gamma Hydroxybutyric Acid—Lymphadenopathy—Doxorubicin—liver cancer	0.00246	0.00366	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00243	0.00743	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—ANXA2—liver cancer	0.00242	0.00739	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00242	0.00359	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00242	0.00738	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00242	0.00738	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Urticaria—Sorafenib—liver cancer	0.0024	0.00357	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Sorafenib—liver cancer	0.00239	0.00355	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—GLUL—liver cancer	0.00232	0.00709	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.00232	0.00709	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00229	0.00699	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Pain in extremity—Epirubicin—liver cancer	0.00227	0.00338	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Sorafenib—liver cancer	0.00223	0.00331	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00218	0.00667	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Sorafenib—liver cancer	0.00217	0.00322	CcSEcCtD
Gamma Hydroxybutyric Acid—Ataxia—Epirubicin—liver cancer	0.00214	0.00318	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood creatinine increased—Epirubicin—liver cancer	0.00213	0.00316	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—HBE1—liver cancer	0.00211	0.00646	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dehydration—Epirubicin—liver cancer	0.00211	0.00314	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain in extremity—Doxorubicin—liver cancer	0.0021	0.00313	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00209	0.00639	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00209	0.00639	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00208	0.00636	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00208	0.00636	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Abdominal pain upper—Epirubicin—liver cancer	0.00207	0.00308	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Sorafenib—liver cancer	0.00207	0.00307	CcSEcCtD
Gamma Hydroxybutyric Acid—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00205	0.00304	CcSEcCtD
Gamma Hydroxybutyric Acid—Nasopharyngitis—Epirubicin—liver cancer	0.00203	0.00302	CcSEcCtD
Gamma Hydroxybutyric Acid—Alanine aminotransferase increased—Epirubicin—liver cancer	0.002	0.00298	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscular weakness—Epirubicin—liver cancer	0.002	0.00298	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Sorafenib—liver cancer	0.002	0.00297	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—PIK3CB—liver cancer	0.00198	0.00605	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00198	0.00605	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Abdominal distension—Epirubicin—liver cancer	0.00198	0.00294	CcSEcCtD
Gamma Hydroxybutyric Acid—Ataxia—Doxorubicin—liver cancer	0.00198	0.00294	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood creatinine increased—Doxorubicin—liver cancer	0.00197	0.00293	CcSEcCtD
Gamma Hydroxybutyric Acid—Influenza—Epirubicin—liver cancer	0.00196	0.00292	CcSEcCtD
Gamma Hydroxybutyric Acid—Dehydration—Doxorubicin—liver cancer	0.00195	0.00291	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Orphan transporters—CYCS—liver cancer	0.00193	0.00588	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Sorafenib—liver cancer	0.00192	0.00286	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain upper—Doxorubicin—liver cancer	0.00192	0.00285	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Sorafenib—liver cancer	0.0019	0.00283	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Sorafenib—liver cancer	0.0019	0.00283	CcSEcCtD
Gamma Hydroxybutyric Acid—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00189	0.00281	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Sorafenib—liver cancer	0.00189	0.00281	CcSEcCtD
Gamma Hydroxybutyric Acid—Nasopharyngitis—Doxorubicin—liver cancer	0.00188	0.00279	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscular weakness—Doxorubicin—liver cancer	0.00185	0.00276	CcSEcCtD
Gamma Hydroxybutyric Acid—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00185	0.00276	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal distension—Doxorubicin—liver cancer	0.00183	0.00272	CcSEcCtD
Gamma Hydroxybutyric Acid—Influenza—Doxorubicin—liver cancer	0.00182	0.0027	CcSEcCtD
Gamma Hydroxybutyric Acid—Pollakiuria—Epirubicin—liver cancer	0.00181	0.0027	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Sorafenib—liver cancer	0.00179	0.00267	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight increased—Epirubicin—liver cancer	0.00179	0.00266	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—GLUL—liver cancer	0.00178	0.00543	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Weight decreased—Epirubicin—liver cancer	0.00178	0.00264	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperglycaemia—Epirubicin—liver cancer	0.00177	0.00263	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Epirubicin—liver cancer	0.00175	0.0026	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Epirubicin—liver cancer	0.00175	0.0026	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Epirubicin—liver cancer	0.00171	0.00254	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—CYCS—liver cancer	0.00169	0.00517	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Pollakiuria—Doxorubicin—liver cancer	0.00168	0.0025	CcSEcCtD
Gamma Hydroxybutyric Acid—Haematuria—Epirubicin—liver cancer	0.00167	0.00248	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight increased—Doxorubicin—liver cancer	0.00165	0.00246	CcSEcCtD
Gamma Hydroxybutyric Acid—Epistaxis—Epirubicin—liver cancer	0.00165	0.00246	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight decreased—Doxorubicin—liver cancer	0.00164	0.00244	CcSEcCtD
Gamma Hydroxybutyric Acid—Sinusitis—Epirubicin—liver cancer	0.00164	0.00244	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperglycaemia—Doxorubicin—liver cancer	0.00164	0.00244	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Doxorubicin—liver cancer	0.00162	0.00241	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Doxorubicin—liver cancer	0.00162	0.00241	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—SERPINA1—liver cancer	0.0016	0.00489	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—UGDH—liver cancer	0.00159	0.00485	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Stomatitis—Doxorubicin—liver cancer	0.00158	0.00235	CcSEcCtD
Gamma Hydroxybutyric Acid—Rhinitis—Epirubicin—liver cancer	0.00158	0.00234	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Epirubicin—liver cancer	0.00156	0.00232	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Epirubicin—liver cancer	0.00156	0.00232	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Epirubicin—liver cancer	0.00155	0.00231	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Epirubicin—liver cancer	0.00155	0.0023	CcSEcCtD
Gamma Hydroxybutyric Acid—Haematuria—Doxorubicin—liver cancer	0.00154	0.0023	CcSEcCtD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Epirubicin—liver cancer	0.00154	0.0023	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Epirubicin—liver cancer	0.00154	0.00229	CcSEcCtD
Gamma Hydroxybutyric Acid—Epistaxis—Doxorubicin—liver cancer	0.00153	0.00227	CcSEcCtD
Gamma Hydroxybutyric Acid—Sinusitis—Doxorubicin—liver cancer	0.00152	0.00226	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—EPT1—liver cancer	0.00149	0.00456	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Eye disorder—Epirubicin—liver cancer	0.00147	0.00218	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Epirubicin—liver cancer	0.00147	0.00218	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—F2—liver cancer	0.00146	0.00446	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Cardiac disorder—Epirubicin—liver cancer	0.00146	0.00217	CcSEcCtD
Gamma Hydroxybutyric Acid—Rhinitis—Doxorubicin—liver cancer	0.00146	0.00217	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Doxorubicin—liver cancer	0.00145	0.00215	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Doxorubicin—liver cancer	0.00144	0.00215	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Doxorubicin—liver cancer	0.00144	0.00214	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Doxorubicin—liver cancer	0.00143	0.00213	CcSEcCtD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Doxorubicin—liver cancer	0.00143	0.00212	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Epirubicin—liver cancer	0.00143	0.00212	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Doxorubicin—liver cancer	0.00143	0.00212	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Epirubicin—liver cancer	0.00142	0.00211	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Epirubicin—liver cancer	0.00142	0.00211	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—TAT—liver cancer	0.00142	0.00432	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Chills—Epirubicin—liver cancer	0.00141	0.0021	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Epirubicin—liver cancer	0.00139	0.00206	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Epirubicin—liver cancer	0.00138	0.00205	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Epirubicin—liver cancer	0.00137	0.00203	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Doxorubicin—liver cancer	0.00136	0.00202	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Doxorubicin—liver cancer	0.00136	0.00202	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Orphan transporters—PPARA—liver cancer	0.00135	0.00413	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Cardiac disorder—Doxorubicin—liver cancer	0.00135	0.00201	CcSEcCtD
Gamma Hydroxybutyric Acid—Tension—Epirubicin—liver cancer	0.00134	0.002	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Epirubicin—liver cancer	0.00134	0.00199	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervousness—Epirubicin—liver cancer	0.00133	0.00198	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Epirubicin—liver cancer	0.00132	0.00197	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Doxorubicin—liver cancer	0.00132	0.00196	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—KRAS—liver cancer	0.00132	0.00402	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Muscle spasms—Epirubicin—liver cancer	0.00132	0.00196	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Doxorubicin—liver cancer	0.00131	0.00195	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—SLC-mediated transmembrane transport—ALB—liver cancer	0.00131	0.00401	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Doxorubicin—liver cancer	0.00131	0.00195	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ANXA2—liver cancer	0.00131	0.00399	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Chills—Doxorubicin—liver cancer	0.0013	0.00194	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Epirubicin—liver cancer	0.00129	0.00192	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Doxorubicin—liver cancer	0.00128	0.00191	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—CYCS—liver cancer	0.00128	0.0039	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Mental disorder—Doxorubicin—liver cancer	0.00127	0.00189	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Doxorubicin—liver cancer	0.00127	0.00188	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Epirubicin—liver cancer	0.00126	0.00188	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Epirubicin—liver cancer	0.00126	0.00187	CcSEcCtD
Gamma Hydroxybutyric Acid—Tension—Doxorubicin—liver cancer	0.00124	0.00185	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Doxorubicin—liver cancer	0.00124	0.00184	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00124	0.00378	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nervousness—Doxorubicin—liver cancer	0.00123	0.00183	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Epirubicin—liver cancer	0.00123	0.00183	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Epirubicin—liver cancer	0.00123	0.00182	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Doxorubicin—liver cancer	0.00122	0.00182	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Doxorubicin—liver cancer	0.00122	0.00181	CcSEcCtD
Gamma Hydroxybutyric Acid—Palpitations—Epirubicin—liver cancer	0.00121	0.0018	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—PIK3CA—liver cancer	0.00121	0.00369	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Loss of consciousness—Epirubicin—liver cancer	0.0012	0.00179	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IFNA1—liver cancer	0.00119	0.00364	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vision blurred—Doxorubicin—liver cancer	0.00119	0.00177	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Epirubicin—liver cancer	0.00119	0.00176	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Epirubicin—liver cancer	0.00118	0.00176	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00118	0.0036	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Anaemia—Doxorubicin—liver cancer	0.00117	0.00174	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Epirubicin—liver cancer	0.00116	0.00173	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Epirubicin—liver cancer	0.00116	0.00173	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Epirubicin—liver cancer	0.00116	0.00173	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Doxorubicin—liver cancer	0.00116	0.00173	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Epirubicin—liver cancer	0.00116	0.00173	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00116	0.00172	CcSEcCtD
Gamma Hydroxybutyric Acid—Dry mouth—Epirubicin—liver cancer	0.00114	0.00169	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Doxorubicin—liver cancer	0.00114	0.00169	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Doxorubicin—liver cancer	0.00114	0.00169	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00113	0.00345	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00113	0.00345	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Confusional state—Epirubicin—liver cancer	0.00113	0.00167	CcSEcCtD
Gamma Hydroxybutyric Acid—Palpitations—Doxorubicin—liver cancer	0.00112	0.00166	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—HRAS—liver cancer	0.00112	0.00341	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Oedema—Epirubicin—liver cancer	0.00112	0.00166	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Doxorubicin—liver cancer	0.00111	0.00165	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—HMOX1—liver cancer	0.00111	0.00339	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Infection—Epirubicin—liver cancer	0.00111	0.00165	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Epirubicin—liver cancer	0.0011	0.00163	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Doxorubicin—liver cancer	0.0011	0.00163	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Epirubicin—liver cancer	0.00109	0.00163	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Doxorubicin—liver cancer	0.00109	0.00162	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Epirubicin—liver cancer	0.00108	0.00161	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Epirubicin—liver cancer	0.00108	0.0016	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Doxorubicin—liver cancer	0.00108	0.0016	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Doxorubicin—liver cancer	0.00108	0.0016	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Doxorubicin—liver cancer	0.00108	0.0016	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Doxorubicin—liver cancer	0.00107	0.0016	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—PIK3CB—liver cancer	0.00107	0.00327	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00107	0.00159	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00107	0.00327	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00107	0.00326	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Anorexia—Epirubicin—liver cancer	0.00106	0.00158	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PRKCE—liver cancer	0.00106	0.00322	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dry mouth—Doxorubicin—liver cancer	0.00105	0.00157	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Doxorubicin—liver cancer	0.00104	0.00155	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—SLC-mediated transmembrane transport—ALB—liver cancer	0.00104	0.00317	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Oedema—Doxorubicin—liver cancer	0.00103	0.00154	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Doxorubicin—liver cancer	0.00103	0.00153	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00102	0.00311	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00102	0.00151	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Doxorubicin—liver cancer	0.00102	0.00151	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Doxorubicin—liver cancer	0.00101	0.00151	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Epirubicin—liver cancer	0.00101	0.0015	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—CYCS—liver cancer	0.00101	0.00308	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—ABL1—liver cancer	0.001	0.00307	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Skin disorder—Doxorubicin—liver cancer	0.001	0.00149	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Epirubicin—liver cancer	0.001	0.00149	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IGF2—liver cancer	0.001	0.00305	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Doxorubicin—liver cancer	0.000999	0.00148	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Epirubicin—liver cancer	0.000995	0.00148	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Epirubicin—liver cancer	0.000992	0.00148	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Doxorubicin—liver cancer	0.000985	0.00146	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Epirubicin—liver cancer	0.000983	0.00146	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000976	0.00298	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000976	0.00298	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Decreased appetite—Epirubicin—liver cancer	0.00097	0.00144	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Epirubicin—liver cancer	0.000964	0.00143	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Epirubicin—liver cancer	0.000962	0.00143	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GLUL—liver cancer	0.000962	0.00294	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CPT1B—liver cancer	0.000962	0.00294	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Pain—Epirubicin—liver cancer	0.000955	0.00142	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Epirubicin—liver cancer	0.000955	0.00142	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—HGF—liver cancer	0.000945	0.00288	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000941	0.0014	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Doxorubicin—liver cancer	0.000934	0.00139	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—CSF2—liver cancer	0.000934	0.00285	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NR1H4—liver cancer	0.000928	0.00283	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Paraesthesia—Doxorubicin—liver cancer	0.000928	0.00138	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000923	0.00282	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspnoea—Doxorubicin—liver cancer	0.000921	0.00137	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Epirubicin—liver cancer	0.00092	0.00137	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Doxorubicin—liver cancer	0.000918	0.00137	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Epirubicin—liver cancer	0.000913	0.00136	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTA3—liver cancer	0.000912	0.00278	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspepsia—Doxorubicin—liver cancer	0.000909	0.00135	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Doxorubicin—liver cancer	0.000898	0.00134	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—PPARA—liver cancer	0.000897	0.00274	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000892	0.00133	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Doxorubicin—liver cancer	0.000891	0.00132	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Epirubicin—liver cancer	0.000887	0.00132	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Doxorubicin—liver cancer	0.000883	0.00131	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Doxorubicin—liver cancer	0.000883	0.00131	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Epirubicin—liver cancer	0.000883	0.00131	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000878	0.00268	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—SERPINA1—liver cancer	0.000865	0.00264	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.000859	0.00262	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—UGDH—liver cancer	0.000857	0.00262	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Feeling abnormal—Doxorubicin—liver cancer	0.000851	0.00127	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Doxorubicin—liver cancer	0.000845	0.00126	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTA4—liver cancer	0.000834	0.00255	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypersensitivity—Epirubicin—liver cancer	0.000822	0.00122	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Doxorubicin—liver cancer	0.000821	0.00122	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Doxorubicin—liver cancer	0.000817	0.00121	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTA2—liver cancer	0.000813	0.00248	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—EPT1—liver cancer	0.000806	0.00246	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Epirubicin—liver cancer	0.000801	0.00119	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTA1—liver cancer	0.000784	0.00239	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NAT2—liver cancer	0.000775	0.00237	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—TAT—liver cancer	0.000764	0.00233	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Diarrhoea—Epirubicin—liver cancer	0.000764	0.00114	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Doxorubicin—liver cancer	0.000761	0.00113	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—MAPK14—liver cancer	0.000756	0.00231	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ALDOB—liver cancer	0.000743	0.00227	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Doxorubicin—liver cancer	0.000741	0.0011	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Epirubicin—liver cancer	0.000738	0.0011	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—F2—liver cancer	0.000733	0.00224	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000717	0.00219	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—KRAS—liver cancer	0.00071	0.00217	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Epirubicin—liver cancer	0.00071	0.00106	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CRABP1—liver cancer	0.000709	0.00217	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—PPARA—liver cancer	0.000709	0.00216	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Diarrhoea—Doxorubicin—liver cancer	0.000707	0.00105	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Epirubicin—liver cancer	0.000704	0.00105	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Epirubicin—liver cancer	0.000703	0.00105	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CG—liver cancer	0.000701	0.00214	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Epirubicin—liver cancer	0.000699	0.00104	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Doxorubicin—liver cancer	0.000683	0.00102	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—ALB—liver cancer	0.000667	0.00204	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Epirubicin—liver cancer	0.000663	0.000986	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Doxorubicin—liver cancer	0.000657	0.000977	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—liver cancer	0.000653	0.00199	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Rash—Doxorubicin—liver cancer	0.000651	0.000968	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Doxorubicin—liver cancer	0.000651	0.000968	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Doxorubicin—liver cancer	0.000647	0.000962	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—BRAF—liver cancer	0.000645	0.00197	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IFNA1—liver cancer	0.000645	0.00197	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Ion channel transport—RAF1—liver cancer	0.000638	0.00195	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—HPGDS—liver cancer	0.00062	0.00189	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CD—liver cancer	0.000617	0.00188	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Doxorubicin—liver cancer	0.000614	0.000912	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—SERPINE1—liver cancer	0.00061	0.00186	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—ALB—liver cancer	0.000609	0.00186	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—HRAS—liver cancer	0.000604	0.00184	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—RAF1—liver cancer	0.000603	0.00184	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PRKCE—liver cancer	0.00057	0.00174	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—ALB—liver cancer	0.00056	0.00171	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PSMA4—liver cancer	0.000553	0.00169	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PSMD10—liver cancer	0.000553	0.00169	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—RAF1—liver cancer	0.00055	0.00168	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000545	0.00166	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ABL1—liver cancer	0.000543	0.00166	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IGF2—liver cancer	0.00054	0.00165	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—RAF1—liver cancer	0.000539	0.00165	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GOT2—liver cancer	0.000537	0.00164	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CB—liver cancer	0.000537	0.00164	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—ALB—liver cancer	0.000527	0.00161	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CPT1B—liver cancer	0.000519	0.00159	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GLUL—liver cancer	0.000519	0.00159	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—HGF—liver cancer	0.00051	0.00156	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP2E1—liver cancer	0.000505	0.00154	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CSF2—liver cancer	0.000504	0.00154	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NR1H4—liver cancer	0.000501	0.00153	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—BRAF—liver cancer	0.000495	0.00151	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IL2—liver cancer	0.000494	0.00151	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTA3—liver cancer	0.000492	0.0015	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—RAF1—liver cancer	0.000477	0.00145	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000474	0.00145	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYCS—liver cancer	0.000473	0.00144	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—CYCS—liver cancer	0.00047	0.00144	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GGT1—liver cancer	0.000464	0.00142	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GOT1—liver cancer	0.000464	0.00142	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTA4—liver cancer	0.00045	0.00138	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTA2—liver cancer	0.000439	0.00134	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTA1—liver cancer	0.000423	0.00129	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—VEGFA—liver cancer	0.000419	0.00128	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NAT2—liver cancer	0.000419	0.00128	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTP1—liver cancer	0.000417	0.00127	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—RAF1—liver cancer	0.000413	0.00126	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—HMOX1—liver cancer	0.000411	0.00125	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000409	0.00125	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—MAPK14—liver cancer	0.000408	0.00125	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ALDOB—liver cancer	0.000401	0.00123	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—F2—liver cancer	0.000396	0.00121	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000395	0.00121	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—TGFB1—liver cancer	0.000385	0.00118	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CRABP1—liver cancer	0.000383	0.00117	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTM1—liver cancer	0.000383	0.00117	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000383	0.00117	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CG—liver cancer	0.000379	0.00116	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP1A1—liver cancer	0.000363	0.00111	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—KRAS—liver cancer	0.000357	0.00109	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—MTHFR—liver cancer	0.000338	0.00103	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HPGDS—liver cancer	0.000335	0.00102	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CD—liver cancer	0.000333	0.00102	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PPARA—liver cancer	0.000332	0.00101	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—PPARA—liver cancer	0.00033	0.00101	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—SERPINE1—liver cancer	0.000329	0.00101	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ALB—liver cancer	0.000329	0.001	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CA—liver cancer	0.000328	0.001	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—TP53—liver cancer	0.000317	0.000968	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—HRAS—liver cancer	0.000303	0.000925	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PSMD10—liver cancer	0.000298	0.000911	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PSMA4—liver cancer	0.000298	0.000911	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—RAF1—liver cancer	0.000297	0.000908	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—HRAS—liver cancer	0.000297	0.000906	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GOT2—liver cancer	0.00029	0.000886	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CB—liver cancer	0.00029	0.000886	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ALB—liver cancer	0.000285	0.000869	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CG—liver cancer	0.000284	0.000868	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PPARG—liver cancer	0.000274	0.000838	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP2E1—liver cancer	0.000273	0.000833	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—AKT1—liver cancer	0.000268	0.000817	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IL2—liver cancer	0.000267	0.000814	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000257	0.000786	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYCS—liver cancer	0.000255	0.00078	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GOT1—liver cancer	0.000251	0.000765	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GGT1—liver cancer	0.000251	0.000765	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CD—liver cancer	0.00025	0.000763	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ALB—liver cancer	0.000247	0.000754	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ALB—liver cancer	0.000245	0.00075	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—HRAS—liver cancer	0.000227	0.000694	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—VEGFA—liver cancer	0.000227	0.000692	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTP1—liver cancer	0.000225	0.000687	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000222	0.000678	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HMOX1—liver cancer	0.000222	0.000678	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CB—liver cancer	0.000218	0.000665	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—TGFB1—liver cancer	0.000208	0.000635	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTM1—liver cancer	0.000207	0.000631	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP1A1—liver cancer	0.000196	0.000599	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—KRAS—liver cancer	0.000193	0.000588	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—MTHFR—liver cancer	0.000183	0.000558	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PPARA—liver cancer	0.000179	0.000547	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CA—liver cancer	0.000177	0.00054	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—TP53—liver cancer	0.000171	0.000523	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—HRAS—liver cancer	0.000164	0.0005	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CG—liver cancer	0.000154	0.000469	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PPARG—liver cancer	0.000148	0.000453	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—AKT1—liver cancer	0.000145	0.000441	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CD—liver cancer	0.000135	0.000412	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ALB—liver cancer	0.000133	0.000407	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CA—liver cancer	0.000133	0.000406	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CB—liver cancer	0.000118	0.000359	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—AKT1—liver cancer	0.000109	0.000331	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CA—liver cancer	7.17e-05	0.000219	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—AKT1—liver cancer	5.86e-05	0.000179	CbGpPWpGaD
